What is RNA and how can we use the body's own RNA editing machinery to treat disease? Learn more about the Axiomer RNA editing technology and how we are creating a new class of medicines.
… (2021) DG Birch. Phase 1b/2 interim results of QR-421a RNA therapy in retinitis pigmentosa due to mutations in USH2A … Site Is Required for Neur… Axiomer technology Axiomer RNAediting technology Download link TIDES USA (2022) Gerard …
… RNA technology to benefit patients At ProQR science is … Phase 2/3 Ph 2/3 Axiomer Platform Disease Disease RNA base editing technology. Lilly – up to 5 targets Partnered with …